TARSONS PRODUCTS LIMITED (TARSONS) financials
TARSONS PRODUCTS LIMITED (TARSONS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in thedesigning, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others'including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]
- Market Cap: ₹1,793Cr.
- Current Price: ₹337
- Stock P/E: 87.0
- ROE: 3.58%
- ROCE: 5.65%
- Book Value: ₹127
- Dividend Yield: 0.00%
- 52W High / Low: ₹375/164
In Jun 2026, TARSONS PRODUCTS LIMITED (TARSONS) reported sales ₹86.15 Cr and net profit ₹0.68 Cr.
Annual TTM: sales ₹348 Cr, net profit ₹20 Cr.
Shareholding: Promoters 47.30% (Sep 2026), FIIs 0.55% (Sep 2026), DIIs 0.61% (Sep 2026), Public 51.53% (Sep 2026), No. of Shareholders 80,867% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 80.12 | 76.16 | 93.04 | 71.28 | 80.51 | 83.99 | 97.16 | 86.15 |
| Expenses | 56.62 | 48.24 | 56.07 | 49.05 | 54.37 | 54.85 | 64.59 | 61.98 |
| Operating Profit | 23.50 | 27.92 | 36.97 | 22.23 | 26.14 | 29.14 | 32.57 | 24.17 |
| OPM % | 29.33% | 36.66% | 39.74% | 31.19% | 32.47% | 34.69% | 33.52% | 28.06% |
| Other Income | 10.65 | 2.12 | 6.37 | 4.58 | 7.32 | 8.36 | 7.64 | 6.75 |
| Interest | 4.68 | 4.13 | 4.52 | 4.28 | 4.41 | 5.32 | 5.41 | 5.44 |
| Depreciation | 11.96 | 15.61 | 17.48 | 17.75 | 20.17 | 22.65 | 26.70 | 24.56 |
| Profit before tax | 17.51 | 10.30 | 21.34 | 4.78 | 8.88 | 9.53 | 8.10 | 0.92 |
| Tax % | 26.21% | 26.12% | 26.34% | 25.10% | 26.46% | 25.60% | 32.59% | 26.09% |
| Net Profit | 12.93 | 7.61 | 15.73 | 3.57 | 6.53 | 7.09 | 5.46 | 0.68 |
| EPS in Rs | 2.43 | 1.43 | 2.96 | 0.67 | 1.23 | 1.33 | 1.03 | 0.13 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 176 | 229 | 301 | 283 | 277 | 314 | 333 | 348 |
| Expenses | 107 | 125 | 148 | 153 | 174 | 209 | 223 | 236 |
| Operating Profit | 69 | 103 | 153 | 130 | 103 | 105 | 110 | 112 |
| OPM % | 39% | 45% | 51% | 46% | 37% | 34% | 33% | 32% |
| Other Income | 4 | 5 | 8 | 12 | 14 | 24 | 28 | 30 |
| Interest | 6 | 3 | 4 | 4 | 10 | 18 | 19 | 21 |
| Depreciation | 14 | 14 | 22 | 29 | 38 | 54 | 87 | 94 |
| Profit before tax | 53 | 92 | 135 | 109 | 69 | 58 | 31 | 27 |
| Tax % | 24% | 25% | 25% | 26% | 26% | 26% | 28% | — |
| Net Profit | 41 | 69 | 101 | 81 | 51 | 43 | 23 | 20 |
| EPS in Rs | 7.65 | 12.99 | 18.92 | 15.17 | 9.63 | 8.03 | 4.26 | 3.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 21% | 0% | 0% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.19 | 0.20 | 0.19 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 135 | 197 | 244 | 479 | 559 | 610 | 642 | 665 |
| Borrowings | 65 | 36 | 34 | 22 | 111 | 257 | 231 | 278 |
| Other Liabilities | 12 | 15 | 18 | 33 | 46 | 76 | 107 | 148 |
| Total Liabilities | 212 | 249 | 296 | 544 | 726 | 953 | 991 | 1,102 |
| Fixed Assets | 89 | 92 | 120 | 189 | 225 | 252 | 460 | 661 |
| CWIP | 7 | 19 | 22 | 32 | 119 | 267 | 233 | 159 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 44 |
| Other Assets | 116 | 137 | 153 | 323 | 382 | 434 | 285 | 238 |
| Total Assets | 212 | 249 | 296 | 544 | 726 | 953 | 991 | 1,102 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 51 | 64 | 68 | 83 | 76 | 105 | 110 | 112 |
| Cash from Investing Activity | -34 | -26 | -64 | -138 | -179 | -296 | -52 | -138 |
| Cash from Financing Activity | -18 | -14 | -27 | 130 | 85 | 136 | -54 | 25 |
| Net Cash Flow | -0 | 25 | -23 | 75 | -18 | -55 | 4 | -1 |
| Free Cash Flow | 18 | 38 | 6 | -48 | -113 | -79 | -42 | -14 |
| CFO/OP | 95% | 115% | 89% | 77% | 77% | 119% | 120% | 109% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 47.31% | 47.31% | 47.31% | 47.31% | 47.30% | 47.30% | 47.30% | 47.30% |
| FIIs | 7.51% | 9.53% | 9.14% | 5.82% | 2.46% | 0.87% | 0.15% | 0.55% |
| DIIs | 0.51% | 0.30% | 0.04% | 0.08% | 0.00% | 0.19% | 0.10% | 0.61% |
| Public | 44.69% | 42.89% | 43.50% | 46.79% | 50.23% | 51.65% | 52.44% | 51.53% |
| No. of Shareholders | 96,927 | 93,417 | 90,891 | 88,966 | 87,336 | 84,093 | 83,453 | 80,867 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 91 | 79 | 75 | 79 | 85 | 94 | 86 | 85 |
| Inventory Days | 333 | 365 | 277 | 478 | 642 | 528 | 419 | 387 |
| Days Payable | 14 | 44 | 35 | 75 | 54 | 42 | 36 | 48 |
| Cash Conversion Cycle | 409 | 400 | 317 | 482 | 672 | 580 | 469 | 423 |
| Working Capital Days | 86 | 110 | 108 | 150 | 166 | -24 | 37 | -30 |
| ROCE % | — | 27% | 37% | 35% | 19% | 10% | 9% | 6% |
Tarsons Products Limited
₹1,793Cr.
₹337
₹375/164
87.0
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in thedesigning, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others'including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of TARSONS PRODUCTS LIMITED (TARSONS)?
The reported market capitalisation for TARSONS PRODUCTS LIMITED (TARSONS) is ₹1,793Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of TARSONS?
The current price shown for TARSONS PRODUCTS LIMITED (TARSONS) on Fincrux is ₹337 with a 52-week high/low of ₹375/164.
What is the P/E ratio of TARSONS PRODUCTS LIMITED (TARSONS)?
The stock P/E for TARSONS PRODUCTS LIMITED (TARSONS) is 87.0 on Fincrux, with ROE at 3.58% and ROCE at 5.65%.
What were TARSONS latest quarterly results?
For Jun 2026, TARSONS PRODUCTS LIMITED (TARSONS) reported sales ₹86.15 Cr and net profit ₹0.68 Cr (figures in ₹ crore unless noted).
What are TARSONS annual sales and net profit?
For TTM, TARSONS PRODUCTS LIMITED (TARSONS) shows sales of ₹348 Cr and net profit of ₹20 Cr on the Fincrux profit & loss statement.
Who owns TARSONS PRODUCTS LIMITED (TARSONS)?
Latest shareholding for TARSONS PRODUCTS LIMITED (TARSONS) on Fincrux: Promoters 47.30% (Sep 2026), FIIs 0.55% (Sep 2026), DIIs 0.61% (Sep 2026), Public 51.53% (Sep 2026), No. of Shareholders 80,867% (Sep 2026).
Where can I find TARSONS PRODUCTS LIMITED (TARSONS) financials?
TARSONS PRODUCTS LIMITED (TARSONS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show TARSONS balance sheet and cash flow?
Yes. The TARSONS PRODUCTS LIMITED (TARSONS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.